238 related articles for article (PubMed ID: 25485963)
1. μ-Opioid receptor 6-transmembrane isoform: A potential therapeutic target for new effective opioids.
Convertino M; Samoshkin A; Gauthier J; Gold MS; Maixner W; Dokholyan NV; Diatchenko L
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Oct; 62():61-7. PubMed ID: 25485963
[TBL] [Abstract][Full Text] [Related]
2. Differential Regulation of 6- and 7-Transmembrane Helix Variants of μ-Opioid Receptor in Response to Morphine Stimulation.
Convertino M; Samoshkin A; Viet CT; Gauthier J; Li Fraine SP; Sharif-Naeini R; Schmidt BL; Maixner W; Diatchenko L; Dokholyan NV
PLoS One; 2015; 10(11):e0142826. PubMed ID: 26554831
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional interactions between six-transmembrane μ-opioid receptors and β2-adrenoreceptors modulate opioid signaling.
Samoshkin A; Convertino M; Viet CT; Wieskopf JS; Kambur O; Marcovitz J; Patel P; Stone LS; Kalso E; Mogil JS; Schmidt BL; Maixner W; Dokholyan NV; Diatchenko L
Sci Rep; 2015 Dec; 5():18198. PubMed ID: 26657998
[TBL] [Abstract][Full Text] [Related]
4. Opioid-induced redistribution of 6TM and 7TM μ opioid receptors: A hypothesized mechanistic facilitator model of opioid-induced hyperalgesia.
Wang W; Wang Y; Zhang W; Jin X; Liu Y; Xu S; Lei L; Shen X; Guo X; Xia X; Wang F
Pharmacol Rep; 2016 Aug; 68(4):686-91. PubMed ID: 27116700
[TBL] [Abstract][Full Text] [Related]
5. A novel alternatively spliced isoform of the mu-opioid receptor: functional antagonism.
Gris P; Gauthier J; Cheng P; Gibson DG; Gris D; Laur O; Pierson J; Wentworth S; Nackley AG; Maixner W; Diatchenko L
Mol Pain; 2010 Jun; 6():33. PubMed ID: 20525224
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of novel candidate compounds targeting 6- and 7-transmembrane μ-opioid receptor isoforms.
Muralidharan A; Samoshkin A; Convertino M; Piltonen MH; Gris P; Wang J; Jiang C; Klares R; Linton A; Ji RR; Maixner W; Dokholyan NV; Mogil JS; Diatchenko L
Br J Pharmacol; 2021 Jul; 178(13):2709-2726. PubMed ID: 33782947
[TBL] [Abstract][Full Text] [Related]
7. Peripheral μ-opioid receptor mediated inhibition of calcium signaling and action potential-evoked calcium fluorescent transients in primary afferent CGRP nociceptive terminals.
Baillie LD; Schmidhammer H; Mulligan SJ
Neuropharmacology; 2015 Jun; 93():267-73. PubMed ID: 25721395
[TBL] [Abstract][Full Text] [Related]
8. A new splice of life for the μ-opioid receptor.
Iadarola MJ; Sapio MR; Mannes AJ
J Clin Invest; 2015 Jul; 125(7):2558-61. PubMed ID: 26011639
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence.
Bao Y; Gao Y; Yang L; Kong X; Yu J; Hou W; Hua B
Channels (Austin); 2015; 9(5):235-43. PubMed ID: 26176938
[TBL] [Abstract][Full Text] [Related]
10. A Truncated Six Transmembrane Splice Variant MOR-1G Enhances Expression of the Full-Length Seven Transmembrane
Zhang T; Xu J; Pan YX
Mol Pharmacol; 2020 Oct; 98(4):518-527. PubMed ID: 32723770
[TBL] [Abstract][Full Text] [Related]
11. Opioid μ-receptors as new target for insulin resistance.
Cheng KC; Asakawa A; Li YX; Liu IM; Amitani H; Cheng JT; Inui A
Pharmacol Ther; 2013 Sep; 139(3):334-40. PubMed ID: 23688574
[TBL] [Abstract][Full Text] [Related]
12. Truncated mu opioid GPCR variant involvement in opioid-dependent and opioid-independent pain modulatory systems within the CNS.
Marrone GF; Grinnell SG; Lu Z; Rossi GC; Le Rouzic V; Xu J; Majumdar S; Pan YX; Pasternak GW
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3663-8. PubMed ID: 26976581
[TBL] [Abstract][Full Text] [Related]
13. Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform.
Vasudevan L; Vandeputte M; Deventer M; Wouters E; Cannaert A; Stove CP
Biochem Pharmacol; 2020 Jul; 177():113910. PubMed ID: 32179045
[TBL] [Abstract][Full Text] [Related]
14. Mediation of opioid analgesia by a truncated 6-transmembrane GPCR.
Lu Z; Xu J; Rossi GC; Majumdar S; Pasternak GW; Pan YX
J Clin Invest; 2015 Jul; 125(7):2626-30. PubMed ID: 26011641
[TBL] [Abstract][Full Text] [Related]
15. Peripheral axonal injury results in reduced mu opioid receptor pre- and post-synaptic action in the spinal cord.
Kohno T; Ji RR; Ito N; Allchorne AJ; Befort K; Karchewski LA; Woolf CJ
Pain; 2005 Sep; 117(1-2):77-87. PubMed ID: 16098668
[TBL] [Abstract][Full Text] [Related]
16. Designing safer analgesics: a focus on μ-opioid receptor pathways.
Pergolizzi JV; LeQuang JA; Taylor R; Ossipov MH; Colucci D; Raffa RB
Expert Opin Drug Discov; 2018 Oct; 13(10):965-972. PubMed ID: 30175624
[TBL] [Abstract][Full Text] [Related]
17. Powerful inhibitory action of mu opioid receptors (MOR) on cholinergic interneuron excitability in the dorsal striatum.
Ponterio G; Tassone A; Sciamanna G; Riahi E; Vanni V; Bonsi P; Pisani A
Neuropharmacology; 2013 Dec; 75():78-85. PubMed ID: 23891638
[TBL] [Abstract][Full Text] [Related]
18. Distinct effects of individual opioids on the morphology of spines depend upon the internalization of mu opioid receptors.
Liao D; Grigoriants OO; Wang W; Wiens K; Loh HH; Law PY
Mol Cell Neurosci; 2007 Jul; 35(3):456-69. PubMed ID: 17513124
[TBL] [Abstract][Full Text] [Related]
19. The pharmacology of mu analgesics: from patients to genes.
Pasternak GW
Neuroscientist; 2001 Jun; 7(3):220-31. PubMed ID: 11499401
[TBL] [Abstract][Full Text] [Related]
20. Sugar solution analgesia: the effects of glucose on expressed mu opioid receptors.
Kracke GR; Uthoff KA; Tobias JD
Anesth Analg; 2005 Jul; 101(1):64-8, table of contents. PubMed ID: 15976207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
